These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21072166)

  • 1. PP2A1 binding, cell transducing and apoptotic properties of Vpr(77-92): a new functional domain of HIV-1 Vpr proteins.
    Godet AN; Guergnon J; Croset A; Cayla X; Falanga PB; Colle JH; Garcia A
    PLoS One; 2010 Nov; 5(11):e13760. PubMed ID: 21072166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The host-pathogen interaction of human cyclophilin A and HIV-1 Vpr requires specific N-terminal and novel C-terminal domains.
    Solbak SM; Wray V; Horvli O; Raae AJ; Flydal MI; Henklein P; Henklein P; Nimtz M; Schubert U; Fossen T
    BMC Struct Biol; 2011 Dec; 11():49. PubMed ID: 22185200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-apoptotic activity of HIV-1 auxiliary regulatory protein Vpr is subtype-dependent and potently enhanced by nonconservative changes of the leucine residue at position 64.
    Jian H; Zhao LJ
    J Biol Chem; 2003 Nov; 278(45):44326-30. PubMed ID: 14506268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT.
    Andersen JL; DeHart JL; Zimmerman ES; Ardon O; Kim B; Jacquot G; Benichou S; Planelles V
    PLoS Pathog; 2006 Dec; 2(12):e127. PubMed ID: 17140287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gelsolin segment 5 inhibits HIV-induced T-cell apoptosis via Vpr-binding to VDAC.
    Qiao H; McMillan JR
    FEBS Lett; 2007 Feb; 581(3):535-40. PubMed ID: 17254575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr.
    Mahalingam S; Ayyavoo V; Patel M; Kieber-Emmons T; Weiner DB
    J Virol; 1997 Sep; 71(9):6339-47. PubMed ID: 9261351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A.
    Hrimech M; Yao XJ; Branton PE; Cohen EA
    EMBO J; 2000 Aug; 19(15):3956-67. PubMed ID: 10921877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages.
    Jacquot G; Le Rouzic E; David A; Mazzolini J; Bouchet J; Bouaziz S; Niedergang F; Pancino G; Benichou S
    Retrovirology; 2007 Nov; 4():84. PubMed ID: 18039376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Vpr displays natural protein-transducing properties: implications for viral pathogenesis.
    Sherman MP; Schubert U; Williams SA; de Noronha CM; Kreisberg JF; Henklein P; Greene WC
    Virology; 2002 Oct; 302(1):95-105. PubMed ID: 12429519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A C-terminal domain of HIV-1 accessory protein Vpr is involved in penetration, mitochondrial dysfunction and apoptosis of human CD4+ lymphocytes.
    Arunagiri C; Macreadie I; Hewish D; Azad A
    Apoptosis; 1997; 2(1):69-76. PubMed ID: 14646566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of apoptosis induced by HIV-1 Vpr and examination of the possible role of the hHR23A protein.
    Gaynor EM; Chen IS
    Exp Cell Res; 2001 Jul; 267(2):243-57. PubMed ID: 11426943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis.
    Lum JJ; Cohen OJ; Nie Z; Weaver JG; Gomez TS; Yao XJ; Lynch D; Pilon AA; Hawley N; Kim JE; Chen Z; Montpetit M; Sanchez-Dardon J; Cohen EA; Badley AD
    J Clin Invest; 2003 May; 111(10):1547-54. PubMed ID: 12750404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair.
    Withers-Ward ES; Jowett JB; Stewart SA; Xie YM; Garfinkel A; Shibagaki Y; Chow SA; Shah N; Hanaoka F; Sawitz DG; Armstrong RW; Souza LM; Chen IS
    J Virol; 1997 Dec; 71(12):9732-42. PubMed ID: 9371639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between the HIV-1 protein Vpr and the adenine nucleotide translocator.
    Sabbah EN; Druillennec S; Morellet N; Bouaziz S; Kroemer G; Roques BP
    Chem Biol Drug Des; 2006 Feb; 67(2):145-54. PubMed ID: 16492162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of Vpr into human immunodeficiency virus type 1 requires a direct interaction with the p6 domain of the p55 gag precursor.
    Bachand F; Yao XJ; Hrimech M; Rougeau N; Cohen EA
    J Biol Chem; 1999 Mar; 274(13):9083-91. PubMed ID: 10085158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2.
    Jacotot E; Ferri KF; El Hamel C; Brenner C; Druillennec S; Hoebeke J; Rustin P; Métivier D; Lenoir C; Geuskens M; Vieira HL; Loeffler M; Belzacq AS; Briand JP; Zamzami N; Edelman L; Xie ZH; Reed JC; Roques BP; Kroemer G
    J Exp Med; 2001 Feb; 193(4):509-19. PubMed ID: 11181702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinuclear localization of the HIV-1 regulatory protein Vpr is important for induction of G2-arrest.
    Sörgel S; Fraedrich K; Votteler J; Thomas M; Stamminger T; Schubert U
    Virology; 2012 Oct; 432(2):444-51. PubMed ID: 22832123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual role of the HIV-1 vpr protein in the modulation of the apoptotic response of T cells.
    Conti L; Matarrese P; Varano B; Gauzzi MC; Sato A; Malorni W; Belardelli F; Gessani S
    J Immunol; 2000 Sep; 165(6):3293-300. PubMed ID: 10975846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The apoptosis-inducing effects of HIV Vpr recombinant eukaryotic expression vectors with different mutation sites on transfected Hela cells.
    Zheng Y; Zhou H; Zhang C; He Y; Li H; Chen Z; Liu M
    Curr HIV Res; 2009 Sep; 7(5):519-25. PubMed ID: 19925402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yeast perspectives on HIV-1 VPR.
    Zhao Y; Elder RT
    Front Biosci; 2000 Dec; 5():D905-16. PubMed ID: 11102318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.